References
- Aust M et al. Platelet-rich Plasma for Skin Rejuvenation and Treatment of Actinic Elastosis in the Lower Eyelid Area. Cureus. 2018 Jul 18;10(7):e2999.
- Graziani F et al. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res. 2006 Apr;17(2):212-9.
- Wang X et al. Behavior of Gingival Fibroblasts on Titanium Implant Surfaces in Combination with either Injectable-PRF or PRP. Int J Mol Sci. 2017 Feb 4;18(2). pii: E331.
- Loibl M et al. The effect of leukocyte-reduced platelet-rich plasma on the proliferation of autologous adipose-tissue derived mesenchymal stem cells. Clin Hemorheol Microcirc. 2016;61(4):599-614.
- Magalon J et al. Product analysis: PRP. IMCAS World Congress, Paris, France. 2017, 2018, 2019, 2020.
- Hetz SP et al. Patient Satisfaction and Clinical Effects of Platelet-Rich Plasma on Pattern Hair Loss in Male and Female Patients. Cureus. 2022 Sep 5;14(9):e28801.
- Smith PA. Intra-articular Autologous Conditioned Plasma Injections Provide Safe and Efficacious Treatment for Knee Osteoarthritis: An FDA-Sanctioned, Randomized, Double-blind, Placebo-controlled Clinical Trial. Am J Sports Med. 2016 Apr;44(4):884-91.
Arthrex
Arthrex is the global market leader for PRP/PRF systems and has been distributing its high-quality medical products for over 10 years in fields such as aesthetic medicine, dermatology, orthopedics, and plastic surgery.
Other innovative products and techniques, such as the ACA technique for harvesting microfat and stromal vascular fraction (SVF), in addition to our unique training programs, help Arthrex to achieve its mission of Helping Surgeons Treat Their Patients Better.
More than 18,000 medical devices
28 Subsidiaries
6 Wetlabs
More than 6000 employees
Upcoming Events
Arthrex Personalized Cell Therapy Symposium_21-22/11/2024
November 21-22, 2024
Munich